logo/base Created with Sketch.
Download the brochure

Guided VCTE®

Seamless liver health assessment for all

As a leader in liver health, we have elevated our core liver elastography technology to the next level with the introduction of Guided VCTE® – our Next-Generation FibroScan® technology.

chevron chevron

Faster examinations with improved guidance

Guided VCTE® indicators

Two new visual indicators allow operators to quickly identify the optimal measurement location.1 Computed by a continuous vibration of the probe transducer, these indicators intuitively guide the operator throughout the entire duration of the exam.

Time savings for all adult patient morphologies

With Guided VCTE®, 96% of patients can be scanned in less than 4 minutes, including patients with BMI≥35.

AutoScan: New efficiency feature

Based on the Guided VCTE® indicators, AutoScan automatically triggers 10 valid measurements through a single click, enabling streamlined scanning and a likely improved operator experience.

Discover in video

Technology Spotlight Webinar: How Guided VCTE® Can Optimize Operator & Physician Experience

In this webinar, hear from key leaders in liver health detail their experience using the next-generation FibroScan® system, equipped with new Guided VCTE® technology.

Learn more about how this technology impacts both the operator and physician experience, with a focus on optimizing liver health management through efficiency and standardization.

Watch the replay

The Technology Behind Guided VCTE®

This white paper provides a technology overview of Guided VCTE® and its associated benefits.

Download the white paper

Our liver health solutions

  • FibroScan® Mini+ 430

    FibroScan® by echosens

    The non-invasive solution for comprehensive management of liver health

    chevron
  • Liver Health Management

    Liver Health Management

    Cloud-based solution to assist clinicians in providing comprehensive liver care.

    chevron
  • FibroScan® Gateway

    FibroScan® Gateway

    Optimize clinical workflows with real-time secure data transmission

    chevron

  • myFibroScan

    Your everyday FibroScan® companion – free application

    chevron

Guided VCTE® is endorsed by healthcare professionals

Guided VCTE helps improve operator efficiency and perhaps standardize their performance. We expect that Guided VCTE features will improve the reliability of LSM without prolonging the study duration, even in patients with MASLD.

Dr. Raj Vuppalanchi

Professor of Medicine, Director of Hepatology and Associate Program Director | Indiana University School of Medicine

The addition of Guided VCTE to SmartExam represents another major advancement in liver diagnostic technology, offering enhanced quality and consistency in examination with a FibroScan system. This innovation has the potential to streamline diagnostic workflows, and strengthen confidence in liver health assessments.

Louise Campbell

Nurse specialist – Fellow of the Royal College of Physicians and Clinical Director at Tawazun Health

One of the standout benefits of the Guided VCTE enhancement is the improved quality and consistency of the FibroScan results obtained. By incorporating Guided VCTE, as healthcare providers we can achieve more accurate and reliable assessments of liver stiffness, leading to improved diagnostic outcomes for patients. This is particularly important in the context of liver health and disease, as early detection and accurate monitoring are essential for optimal patient care.

Louise Campbell

Nurse specialist – Fellow of the Royal College of Physicians and Clinical Director at Tawazun Health

Watch our operators' perspective in video chevron

Request a demo!

Interested in FibroScan®?

Contact us

* Without SmartExam, the maximum recommended Probe-to-Capsula distance (PCD) is 35 mm. With SmartExam, it is 45mm, representing an increase of 28%.

References

1. Bastard, Cécile et al. “Guided-VCTE: An Enhanced FibroScan Examination With Improved Guidance and Applicability.” Ultrasound in medicine & biology vol. 51,4 (2025): 628-637.
2. E. Bardou-Jacquet et al. Validation of the Continuous Controlled Attenuation Parameter (CAPc) using the MRI-PDFF as reference. EASL 2022 poster #FRI-228.

Products in the FibroScan® range are Class IIa medical devices as defined by Directive 93/42/EEC (EC 0459) and are manufactured by Echosens™. These devices are designed for use in a medical practice in order to measure liver stiffness and ultrasound attenuation in patients with liver disease. Examinations with FibroScan® device shall be performed by an operator who has been certified by the manufacturer or its approved local representative. Operators are expressly recommended to carefully read the instructions given in the user manual and on the labelling of these products. Check cost defrayal conditions with paying bodies. 
The Guided VCTE® technology is only available on the latest FibroScan® systems and can be used only with M+ and XL+ probes.